Gain Therapeutics Competitors and Similar CompaniesClear all
Gain Therapeutics's competitors and similar companies include Ipsen and CSL Behring.
 Gain Therapeutics Gain Therapeutics is a biotech company that targets lysosomal enzymes to develop drugs for pediatric genetic and selected central nervous system disorders. | |||
Founding Date | Founding Date 2017 | Founding Date 1929 | Founding Date 1904 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Bethesda, US HQ Barcelona, ES Lugano, CH | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees 2321% decrease | Employees 5,358 | Employees 7,5692% decrease |
Valuation ($) | Valuation ($) 65.6 m | Valuation ($) 10.2 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) |
Gross profit | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit $4.5b (FY, 2020) |
Net income | Net income ($20.2m) (FY, 2025) | Net income €445.1m (FY, 2025) | Net income N/A |
Operating ⚠ | |||
Patent Applications | Patent Applications 4 (Feb, 2021) | Patent Applications N/A | Patent Applications 3 (Dec, 2020) |
For sources of this data, please see the company profile